Our in vitro pharmacological analysis services include the generation of stable cell lines, the development of detection methods, the screening of compounds using the developed detection methods, the use of 96-well or 384-well plates to determine the activity characteristics of compounds, and the use of SPR technology for the binding affinity of small compounds and antibodies. Harmony and dynamics test.
Metabolic diseases
Autoimmune system diseases
Pain and analgesic effects
Neurological and mental illness
Service Program
Establishment of Stable Cell Line
Detection Method Development
Target type:
G protein-coupled receptors, Transporters, Ion Channels
Protein Kinase
Epigenetic Target
Other Enzymes: (Phosphodiesterase, ATP Kinase, Protease)
Nucleotide Receptor
Immune Tumor Target
Detection Type
Cytological Function Test
Biochemical Testing
Target Binding Detection
Detection Method
FRET, FP, FACS, ELISA, LCMS
Fluorescence
Biophysical Binding Test
Compound Analysis
96-well and 384-well
5 internally developed human GPCR stable transfection cell lines and 250 human cancer cell lines
are used for panel screening services